Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026)
Galectin Therapeutics' quarterly Prepaid Assets came in at $1.6 million in Q1 2026, down 14.78% year-on-year from $1.9 million in Q1 2025, and down 7.93% quarter-over-quarter from $1.7 million in Q4 2025.
Galectin Therapeutics has reported Prepaid Assets for 17 years, with the latest figure at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 14.78% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 14.78% YoY), and the FY2025 full-year result was $1.7 million, down 19.51% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.6 million, down from $1.7 million in the prior quarter.
- The five-year high for Prepaid Assets was $2.1 million in Q4 2024, with the low at $1.2 million in Q3 2025.
- Average Prepaid Assets over 5 years is $1.7 million, with a median of $1.7 million recorded in 2024.
- Year-over-year, Prepaid Assets grew 28.58% in 2024 and fell 25.03% in 2025.
- Tracing GALT's Prepaid Assets over 5 years: stood at $2.0 million in 2022, then increased by 4.59% to $2.0 million in 2023, then grew by 4.0% to $2.1 million in 2024, then decreased by 19.51% to $1.7 million in 2025, then declined by 7.93% to $1.6 million in 2026.
- The last three Prepaid Assets figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Mar 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 2.32 Mn |
| Sep 30, 2020 | 1.33 Mn |
| Jun 30, 2020 | 352,000.00 |
| Mar 31, 2020 | 556,000.00 |
| Dec 31, 2019 | 729,000.00 |
| Sep 30, 2019 | 136,000.00 |
| Jun 30, 2019 | 652,000.00 |
| Mar 31, 2019 | 511,000.00 |
| Dec 31, 2018 | 579,000.00 |
| Sep 30, 2018 | 394,000.00 |
| Jun 30, 2018 | 541,000.00 |
| Mar 31, 2018 | 685,000.00 |
| Dec 31, 2017 | 766,000.00 |
| Sep 30, 2017 | 53,000.00 |
| Jun 30, 2017 | 202,000.00 |
| Mar 31, 2017 | 353,000.00 |
| Dec 31, 2016 | 432,000.00 |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 239,000.00 |
| Mar 31, 2016 | 425,000.00 |
| Dec 31, 2015 | 554,000.00 |
| Sep 30, 2015 | 183,000.00 |
| Jun 30, 2015 | 305,000.00 |
| Mar 31, 2015 | 611,000.00 |
| Dec 31, 2014 | 533,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 87,000.00 |
| Mar 31, 2014 | 151,000.00 |
| Dec 31, 2013 | 198,000.00 |
| Sep 30, 2013 | 27,000.00 |
| Jun 30, 2013 | 88,000.00 |
| Mar 31, 2013 | 137,000.00 |
| Dec 31, 2012 | 153,000.00 |
| Sep 30, 2012 | 89,000.00 |
| Jun 30, 2012 | 85,000.00 |
| Mar 31, 2012 | 115,000.00 |
| Dec 31, 2011 | 104,000.00 |
| Sep 30, 2011 | 51,000.00 |
| Jun 30, 2011 | 71,000.00 |
| Dec 31, 2010 | 70,000.00 |